RGC

Regencell Bioscience Holdings Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↓ 0/10
  • Momentum↑ 9/10
Regencell Bioscience Holdings sales and earnings growth
RGC Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -133.33%
  • FCF Y/Y↓ -325.68%
Regencell Bioscience Holdings gross and profit margin trends
RGC Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -83.50%
Regencell Bioscience Holdings net debt vs free cash flow
RGC Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Regencell Bioscience Holdings stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗